查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198735

动物麻醉市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Veterinary Anesthesia Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

动物麻醉市场预计在预测期内的复合年增长率为 6.5%。

主要亮点

  • COVID-19 大流行扰乱了多个国家/地区的兽医设备供应链，这主要是由于生产基地暂时关闭、出口禁令以及对治疗 COVID-19 的药物的需求增加。兽医手术的中断和取消影响了动物麻醉市场。
  • 例如，根据 2021 年 2 月发表的一篇文章，墨西哥在 COVID-19 大流行期间经历了兽医服务需求和宠物诊所就诊量的下降，影响了动物麻醉市场的增长。据说 然而，随着限制的解除和宠物诊所服务的重新开放，市场正在復苏。
  • 此外，与外科手术相关的慢性病的增加以及动物麻醉技术的进步对所调查市场的增长产生了积极影响。
  • 近年来，关节炎、慢性肾病、肝炎、皮肤过敏（特应性）、糖尿病、库欣病、艾迪生病、炎症性肠病、甲亢（猫）、甲减（犬）等慢性病的流行越来越明显。 因此，随着这些疾病的高患病率，预计在预测期内手术数量将会增加。
  • 根据 Frontiers of Veterinary Science 报告的数据，2021 年西班牙狗的肥胖和肥胖相关代谢功能障碍 (ORMD)（例如高血压和空腹高甘油三酯血症/高胆固醇血症）的患病率分别为 40.9% 和 20.4%。 由于狗的肥胖率很高，需要麻醉的外科手术的增加预计将促进市场的增长。
  • 此外，根据 2021 年 7 月发表在《动物科学杂誌》上的一篇论文，北美每年约有 20% 的成年犬患有骨关节炎 (OA)，超过 90% 的 20 岁以上犬隻患有骨关节炎 (OA) 5. 已报告受影响。 这种疾病的高负担需要在手术过程中使用麻醉，这推动了市场增长。
  • 主要市场参与者采取的战略举措（例如产品发布、批准和合作伙伴关係）正在推动市场增长。 例如，2021年4月，深圳迈瑞动物医疗科技推出了一款名为Veta 5或Veta 3的新型动物麻醉设备。 此类产品的推出有望推动市场增长。
  • 但是，麻醉机的高成本可能会阻碍市场增长。

兽用麻醉市场趋势

预计在预测期内伴□□侣动物部分将占据重要的市场份额

  • 由于慢性病的增加、宠物拥有量的增加以及全球宠物保险的增加，预计伴侣动物部分将占据重要的市场份额。
  • 根据病态动物人民药房 (PDSA) 2021 年 6 月的动物福利报告，2020 年 3 月至 2021 年 5 月期间，英国有 200 万人收养了宠物。 这些宠物中，10%是狗，8%是猫，13%是兔子。 根据 Der Deutsche Heimtiermarkt 的数据，到 2021 年，德国 47% 的家庭将养宠物。
  • 此外，全国宠物（包括观赏鸟类和小动物、狗和猫）的数量达到了 3470 万隻。 1670 万隻猫生活在 26% 的德国家庭中，而 1030 万隻狗生活在 21% 的家庭中，这表明德国收养的猫多于狗。我是。 由于每个国家的宠物主人和人口众多，对动物保健的关注度越来越高。 因此，正在进行更多的兽医诊断，增加了治疗慢性病所需的麻醉需求，扩大了市场。
  • 此外，根据美国宠物用品协会 (APPA) 的数据，预计 2021 年美国将在宠物上花费约 1096 亿美元，比上一年增长约 6%。 此外，随着该地区宠物拥有量的增加，越来越多的人不得不关注宠物保险的可用性。 结果，宠物主人在宠物保健上花钱。 这开启了创造和利用先进有效的麻醉来有效治疗动物的可能性，并有望在未来几年推动市场增长。
  • 此外，主要参与者采取的战略举措（例如产品发布和批准）推动了该细分市场的增长。 例如，2022 年 1 月，Decra Pharmaceuticals 收购了用于动物手术的 Halocarbon Life Sciences 的 Isoflurane USP Inhalant Anesthetic 和 Sevoflurane USP Inhalant 吸入麻醉溶液。 这些发展预计将推动这一领域的增长。

预计在预测期内，北美将占据重要的市场份额。

  • 由于动物健康意识的提高和不断的创新，预计北美将在动物麻醉市场占有重要份额。
  • 随着宠物保险在该地区的增长，预计市场增长将会扩大。 例如，根据保险信息研究所发布的 2022 年统计数据，到 2021 年底，美国将有 390 万隻宠物投保，比 2020 年增长 20%。 我们还发现，2021 年宠物保险覆盖率最高的三个州是加利福尼亚州 (19.3%)、纽约州 (8.4%) 和佛罗里达州 (6.1%)。
  • 到 2021 年底，加拿大有 432,533 隻宠物投保，比 2020 年增长 22.7%。 2021年，宠物保险覆盖率最高的三个省份分别是安大略省（38.9%）、不列颠哥伦比亚省（20.3%）和艾伯塔省（18.9%）。 该地区宠物保险订户数量的增加也有望推动市场增长。
  • 此外，各种市场参与者为开发有效的动物麻醉而开展的研发活动、产品发布、批准和合作预计将促进市场增长。 例如，2022 年 4 月，Respirair Global 与 Decra US 合作开发异氟醚和七氟醚兽用汽化器和麻醉配件。 该合作伙伴关係旨在扩大兽医麻醉并开发技术先进的产品。 在分析期间，此类新兴市场的发展预计将推动该地区的市场增长。

动物麻醉市场竞争者分析

由于许多公司在全球和区域开展业务，因此动物麻醉市场本质上是分散的。 竞争格局包括对少数拥有主要或重要市场份额的国际和本地公司的分析。 主要公司包括 JD Medical Dist. Co. Inc.、Kent Scientific Corporation、Midmark Corporation、Mindray Medical International Limited、Patterson Scientific、ICU Medical, Inc.、Supera Anesthesia Innovations、Tecnologia Veterinaria y Medica, S.L、Dispomed Ltd.，製造商包括DRE Veterinary、Vetland Medical Sales & Services, LLC、Avante Health Solutions、Prunus Medical 和 Dispomed Ltd. 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 慢性病和相关外科手术的增加
    • 动物麻醉的技术进步
  • 市场製约因素
    • 麻醉机成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 电车
    • 墙型
    • 桌面
  • 按动物分类
    • 同伴
    • 牲畜
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 世界其他地方

第六章竞争格局

  • 公司简介
    • JD Medical Dist. Co. Inc.
    • Kent Scientific Corporation
    • Midmark Corporation
    • Mindray Medical International Limited
    • Patterson Scientific
    • ICU Medical, Inc.
    • Supera Anesthesia Innovations
    • Tecnologia Veterinaria y Medica, S.L
    • Vetland Medical Sales & Services, LLC
    • Avante Health Solutions
    • Dispomed Ltd.
    • Prunus Medical

第7章 市场机会与今后动向

简介目录
Product Code: 64155

The veterinary anesthesia market is expected to register aCAGR of 6.5% during the forecast period.

Key Highlights

  • The COVID-19 pandemic impacted the veterinary anesthesia market owing to the disruptions in the veterinary medical devices supply chain and cancellations of veterinary surgical procedures in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19.
  • For instance, according to an article published in February 2021, the demand for veterinary services and visits to pet clinics reduced in Mexico during the COVID-19 pandemic, thus impacting the growth of the veterinary anesthesia market. However, the market recovered since the restrictions were lifted and pet clinic services resumed.
  • In addition, the rising chronic diseases associated with surgical procedures and technological advancements in veterinary anesthesia are actively affecting the growth of the studied market.
  • The recent years have observed a significant rise in the prevalence of veterinary chronic diseases, such as arthritis, chronic kidney disease, hepatitis, skin allergies (atopy), diabetes mellitus, Cushing's and Addison's disease, inflammatory bowel disease, hyperthyroidism (cats) and hypothyroidism (dogs), and many others. Hence, with the high prevalence of these diseases, the number of surgical procedures is expected to rise during the forecast period.
  • According to the data reported by Frontiers of Veterinary Science, the prevalence of canine obesity and obesity-related metabolic dysfunction (ORMD), such as hypertension and fasting hypertriglyceridemia/hypercholesterolemia, was reported to be 40.9% and 20.4%, respectively, in Spain in 2021. The high prevalence of canine obesity is expected to increase the surgical procedures requiring anesthesia, thereby boosting market growth.
  • Furthermore, an article published in the Journal of Animal Science in July 2021 reported that osteoarthritis (OA) affects about 20% of all adult dogs and over 90% of dogs above five years of age in North America every year. The high burden of the disease requires the use of anesthesia during surgical treatment, thereby propelling the market growth.
  • The strategic initiatives adopted by key market players, such as product launches, approvals, and partnerships, are driving the market growth. For instance, in April 2021, Shenzhen Mindray Animal Medical Technology Co., Ltd. launched its new veterinary anesthesia device called Veta 5 or Veta 3. The product launches are anticipated to propel the market growth.
  • However, the high cost of anesthesia machines will likely impede the market growth.

Veterinary Anesthesia Market Trends

Companion Segment is Expected to Hold a Significant Market Share Over the Forecast Period

  • The companion animal segment is expected to hold a significant market share owing to the increasing prevalence of chronic diseases, rise in pet adoption, and rising pet insurance globally.
  • According to the People's Dispensary for Sick Animals (PDSA) animal wellbeing June 2021 report, 2 million people in the United Kingdom adopted a pet between March 2020 to May 2021. Of these pets, 10% were dogs, 8% were cats, and 13% were rabbits. Also, according to Der Deutsche Heimtiermarkt, 47% of the households in Germany had pets in 2021.
  • Additionally, there were 34.7 million pets in the country, including decorative birds, small animals, and dogs and cats. The number of cats adopted was higher in Germany than in dogs, as 16.7 million cats live in 26% of German households compared to 10.3 million dogs in 21% of households. Such a high rate of pet adoption and population in different countries has increased the focus on the healthcare of animals. This has increased the incidences of veterinary diagnostics, thus increasing the demand for anesthesia required for treating chronic diseases, thereby boosting the market.
  • Furthermore, according to the American Pet Products Association (APPA), it was estimated that in 2021 around USD 109.6 billion was spent on pets in the United States, an increase of approximately 6% from the previous year. The region's increasing pet adoption rate is also forcing more people to pay attention to the availability of pet insurance. Hence, pet owners are spending more on pet health care. This is opening up possibilities for the creation and availability of advanced and effective anesthesia for the effective treatment of animals, which is expected to drive market growth over the coming years.
  • Besides, the strategic initiatives adopted by key players, such as product launches and approvals, fuel the segment growth. For instance, in January 2022, Dechra Pharmaceuticals acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant inhalation anesthesia solutions from Halocarbon Life Sciences, used for animal surgeries. These developments are projected to propel the segment's growth.

North America is Expected to Hold a Significant Market Share Over The Forecast Period.

  • North America is expected to hold a significant share of the veterinary anesthesia market due to increased awareness about animal health and ongoing technological innovations.
  • The increasing number of pet insurance in the region is expected to increase the market growth. For instance, according to the 2022 statistics published by the Insurance Information Institute, it has been observed that in the United States, 3.9 million pets were insured at the end of 2021, with an increase of 20% compared to 2020. In addition, California (19.3%), New York (8.4%), and Florida (6.1%) were the three states with the highest percentage of insured pets in 2021.
  • Also, it has been observed that in Canada 432,533 pets were insured at the end of 2021, with an increase of 22.7% compared to 2020. Also, Ontario (38.9%), British Columbia (20.3%), and Alberta (18.9%) were the three states with the highest percentage of insured pets in 2021. The rising number of pet insurance in the region is also expected to increase the market growth.
  • Furthermore, the research and development activities of various market players to develop effective veterinary anesthesia, product launches, approvals, and partnerships are anticipated to boost the market growth. For instance, in April 2022, Respirair Global collaborated with Dechra United States for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. The partnership aims to expand veterinary anesthesia and develop technologically advanced products. Such developments are anticipated to boost the market growth in the region during the analysis period.

Veterinary Anesthesia Market Competitor Analysis

The veterinary anesthesia market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies with major or significant market shares. Some key players are JD Medical Dist. Co. Inc., Kent Scientific Corporation, Midmark Corporation, Mindray Medical International Limited, Patterson Scientific, ICU Medical, Inc, Supera Anesthesia Innovations, Tecnologia Veterinaria y Medica, S.L, Dispomed Ltd., DRE Veterinary, Vetland Medical Sales & Services, LLC, Avante Health Solutions, Prunus Medical, and Dispomed Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Chronic Diseases And Associated Surgical Procedures
    • 4.2.2 Technological Advancements in Veterinary Anesthesia
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Anesthesia Machines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 On Trolley
    • 5.1.2 Wall Mounted
    • 5.1.3 Table top
  • 5.2 By Animals
    • 5.2.1 Companion
    • 5.2.2 Livestock
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 JD Medical Dist. Co. Inc.
    • 6.1.2 Kent Scientific Corporation
    • 6.1.3 Midmark Corporation
    • 6.1.4 Mindray Medical International Limited
    • 6.1.5 Patterson Scientific
    • 6.1.6 ICU Medical, Inc.
    • 6.1.7 Supera Anesthesia Innovations
    • 6.1.8 Tecnologia Veterinaria y Medica, S.L
    • 6.1.9 Vetland Medical Sales & Services, LLC
    • 6.1.10 Avante Health Solutions
    • 6.1.11 Dispomed Ltd.
    • 6.1.12 Prunus Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS